Target intelligence / Profile preview

Microbial protein or enzyme

Molecular classification
Enzyme, Protein, Other (as a broad class rather than a single molecule)
01

Overview

Microbial proteins and enzymes" is not the name of a specific molecular target but rather refers broadly to the diverse set of **proteins and enzymes produced by microorganisms** such as bacteria and fungi. These biomolecules are widely used in medicine both as direct therapeutics—such as **streptokinase** for clot dissolution or **asparaginase** for leukemia treatment—and as targets for antimicrobial drugs that inhibit essential microbial functions. Some microbial enzymes act directly on human substrates; others serve as virulence factors targeted by monoclonal antibodies or small-molecule inhibitors. The category includes proteases, glycosidases, oxidases, ligases, among many others. Because this term encompasses an entire class rather than a single defined entity with unique structure/function/disease association, it is considered too broad and non-specific for use as a canonical drug target name.[4][7] If you are seeking structured information about individual targets within this group—such as "Streptokinase," "Asparaginase," "Lysostaphin," etc.—each should be treated separately with its own canonical entry. > *Note*: The entry "Microbial proteins and enzymes" is overly generic; it does not refer to one specific molecule but instead covers an entire functional class spanning multiple unrelated families with distinct biological roles.[4][7]

Other names
Microbial enzymeBacterial proteinFungal enzymeTherapeutic microbial enzymeMicrobial therapeutic protein
02

Mechanism of action

Enzymatic degradation of target molecules or structures[2][3][5] - e.g., Streptokinase activates plasminogen to dissolve blood clots[2] - Asparaginase depletes asparagine to inhibit leukemic cell growth[5] - Lysostaphin cleaves peptidoglycan in bacterial cell walls[2]

03

Biological functions

Catalysis of biochemical reactionsSignal transduction (for some proteins)Immune modulation (for some proteins/enzymes)Pathogen virulence factor (in infectious disease context)
04

Disease associations

InfectionCancerCardiovascular disease
05

Safety considerations

Immunogenicity and allergic reactions to non-human proteins/enzymes[7][8]Off-target effects due to broad substrate specificity in some enzymes[7][8]
06

Interacting drugs

Streptokinase (thrombolytic agent)[2]

2 more in the full profile.

Beyond the preview

Go deeper on Microbial protein or enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial protein or enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call